Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.49 (
reverse transcriptase
)
31,746
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We investigated whether natural killer (NK) cells in the tumor microenvironment have a radiosensitization effect. The radiosensitization effect of combined CpG and
Herceptin
((R)) (Genentech, Inc., South San Francisco, CA) (CpG/
Herceptin
), given before or after radiation, was evaluated by using a murine colon cancer cell line overexpressing human HER2/neu, CT26HER2/neu. In vitro radiosensitization effects were investigated by coculture of CT26HER2/neu with splenocytes, CpG, and
Herceptin
before applying radiation. Tumor cells, cocultured with CpG-pretreated splenocytes and
Herceptin
, were more vulnerable to radiation damage. In BALB/c mice injected with CT26HER2/neu, CpG/
Herceptin
administered before radiotherapy was associated with a better retardation of tumor growth than when administered after radiotherapy. The radiosensitization effect was significantly abrogated by NK-cell depletion, indicating that NK cells play an essential role in it. Further, surviving mice treated with CpG or CpG/
Herceptin
and
reverse transcriptase
were resistant to renewed tumor challenge, suggesting the presence of an induced immune response to the tumor. Neoadjuvant immunotherapy with CpG/
Herceptin
may improve response to radiotherapy of HER2/neu-expressing tumors.
...
PMID:Neoadjuvant immunotherapy enhances radiosensitivity through natural killer cell activation. 2018 95